APA (7th ed.) Citation

Rodríguez-García, M., Salvador-Martín, S., Rojas Piedra, M. S., Bravo, A., Vidal, M., Figueras Gutierrez, C., . . . Brunet, M. (2026). Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive DPYD Pharmacogenetic Testing. Pharmaceuticals (14248247), 19(3), 460. https://doi.org/10.3390/ph19030460

Chicago Style (17th ed.) Citation

Rodríguez-García, María, Sara Salvador-Martín, Mariam Stephanie Rojas Piedra, Adrián Bravo, María Vidal, Carolina Figueras Gutierrez, Joan Maurel, Luis A. López-Fernández, and Mercè Brunet. "Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive DPYD Pharmacogenetic Testing." Pharmaceuticals (14248247) 19, no. 3 (2026): 460. https://doi.org/10.3390/ph19030460.

MLA (9th ed.) Citation

Rodríguez-García, María, et al. "Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive DPYD Pharmacogenetic Testing." Pharmaceuticals (14248247), vol. 19, no. 3, 2026, p. 460, https://doi.org/10.3390/ph19030460.